Medicover to sell India hospital business to KKR for €1.2 billion

• Medicover owns 66.1% of Medicover Hospitals India (MHI), which generated €220.5 million in annual revenue on a last-twelve-months basis as of June 30, 2026
• India accounted for 10% of Medicover's total revenue in the second quarter
• Medicover stated its financial targets remain unchanged until completion of the transaction

Summary

Swedish healthcare provider Medicover has agreed to sell its India hospital business to KKR-managed funds for €1.2 billion ($1.39 billion), with the transaction expected to close in Q4 2026.

Key Transaction Details:

• Medicover will receive gross cash proceeds of €740 million from the divestment
• The company owns 66.1% of Medicover Hospitals India (MHI), with minority shareholders holding the remaining stake
• MHI generated annual revenue of €220.5 million on a last-twelve-months basis as of June 30, 2026
• India operations represented 10% of Medicover's total revenue in Q2

Strategic Rationale:

Medicover stated the sale will enable the company to focus strategically and operationally on its core European markets: Poland, Germany, and Romania. The company confirmed its financial targets remain unchanged until the transaction completes.

Market Implications:

This represents a significant portfolio rationalization move by Medicover, streamlining operations to concentrate on European healthcare markets. For KKR, the acquisition expands its presence in India's growing private healthcare sector, continuing the firm's investment strategy in emerging market healthcare assets.

The deal reflects ongoing consolidation in the global healthcare industry, with private equity firms like KKR actively pursuing opportunities in high-growth markets like India. The extended timeline to Q4 2026 suggests regulatory approvals and complex stakeholder arrangements will be required to finalize the transaction.